ETHACRYNATE SODIUM FOR INJECTION DIN 02479591
Status: Cancelled Pre Market
Holder: ENDO PAR INNOVATION COMPANY, LLC
Molecule: ETHACRYNIC ACID (ETHACRYNATE SODIUM)
Health Canada record
| Active ingredient(s) | ETHACRYNIC ACID (ETHACRYNATE SODIUM) 50 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C03CC01 ETACRYNIC ACID |
| Original market date | |
| Current status date | 07-Jul-2023 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ETHACRYNIC ACID (ETHACRYNATE SODIUM)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02462362 | ETHACRYNATE SODIUM | STERIMAX INC | Powder For Solution | ETHACRYNIC ACID (ETHACRYNATE SODIUM) 50 MG | Marketed |
| 02469456 | ETHACRYNATE SODIUM FOR INJECTION USP | STERIMAX INC | Powder For Solution | ETHACRYNIC ACID (ETHACRYNATE SODIUM) 50 MG | Dormant |
| 00268313 | SODIUM EDECRIN | BAUSCH HEALTH, CANADA INC. | Powder For Solution | ETHACRYNIC ACID (ETHACRYNATE SODIUM) 50 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 21174 | 2018-08-01 | Abbreviated New Drug Submission (ANDS) |